House E&C SubCmte Hearing: Examining Biosecurity at Intersection of AI & Biology
"Examining Biosecurity at the Intersection of AI and Biology"
Committee: House Energy and Commerce
Subcommittee: House Energy and Commerce Subcommittee on Oversight and Investigations
https://energycommerce.house.gov/events/o-and-i-subcommittee-examining-biosecurity-at-the-intersection-of-ai-and-biology
The hearing may include discussion around the following key questions:
• What are the potential benefits of AI-enabled biotechnology?
• How can safe use of AI-enabled biotechnology improve the U.S.’s biosecurity posture?
• What are the actual and potential risks of AI-enabled biotechnology, including those related to biosecurity and biothreats?
• What steps are being taken to protect Americans from the risks of misuse of AI enabled biotechnology?
• Is additional action necessary to protect Americans from misuse of AI-enabled biotechnology?
WITNESSES
Matthew McKnight
General Manager,
Ginkgo Biosecurity, Ginkgo Bioworks
https://www.congress.gov/119/meeting/house/118773/witnesses/HHRG-119-IF02-Wstate-McKnightM-20251217.pdf
James Diggans
Vice President, Policy and Biosecurity, Twist Bioscience Corporation
https://www.congress.gov/119/meeting/house/118773/witnesses/HHRG-119-IF02-Wstate-DiggansJ-20251217.pdf
Jassi Pannu
Assistant Professor, Department of Environmental Health and Engineering and Senior Scholar, Johns Hopkins Bloomberg School of Public Health and Johns Hopkins Center for Health Security
https://www.congress.gov/119/meeting/house/118773/witnesses/HHRG-119-IF02-Wstate-PannuJ-20251217.pdf
Fiona Havers
Former Lead of the Centers for Disease Control and Prevention Respiratory Virus Hospitalization Surveillance Network Team
https://www.congress.gov/119/meeting/house/118773/witnesses/HHRG-119-IF02-Wstate-HaversF-20251217.pdf
MEMO
https://www.congress.gov/119/meeting/house/118773/documents/HHRG-119-IF02-20251217-SD002.pdf
In July 2025, the Trump Administration also released “Winning the Race: America’s AI Action Plan,” which highlights the need for the U.S. government’s investment in biosecurity as a component of AI innovation.68 The AI Action Plan requires all institutions receiving federal funding for scientific research to use nucleic acid synthesis tools and synthesis providers that have customer vetting and screening procedures, rather than relying on voluntary attestation.69 Additionally, OSTP should “convene government and industry actors to develop a mechanism to facilitate data sharing between nucleic acid synthesis providers to screen for potentially fraudulent or malicious customers.”70 The AI Action Plan also includes evaluation of novel national security risks of frontier AI models.
The Trump Administration recently announced the Genesis Mission which aims to develop a coordinated national effort to unleash AI‑accelerated innovation and discovery that can solve the most challenging problems of this century.73 The Genesis Mission proposes to build an integrated AI platform to harness federal scientific datasets to train foundation models and create AI agents to accelerate scientific breakthroughs in many categories, including detecting and countering biological threats.74
IMAGE
https://pmc.ncbi.nlm.nih.gov/articles/PMC12174072/
Streamed by America Mission
== https://x.com/AmericaMission_
Treasury Department’s Dirty Trick on ‘No Tax on Tips’
https://americamission.com/treasury-departments-dirty-trick-on-no-tax-on-tips/
Vote for AM's
Fight Against Federal Overreach Act (FAFO Act)
https://forum.policiesforpeople.com/t/fight-against-federal-overreach-act-fafo-act/26118
Make America Your Mission
🛍️ Shop, Donate, Amplify Your Voice
https://www.americamission.com/make-america-your-mission
Find out where to #ShowUpAndShare
https://linktr.ee/americamission